Skip to content

Role of Homoeopathic medicine in the management of bed wetting in children

Determining the Role of Homoeopathic medicine in the management of Nocturnal enuresis using ORIDL scale: Experimental Self controlled study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078091
Enrollment
83
Registered
2024-12-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N33- Bladder disorders in diseases classified elsewhere

Interventions

Intervention1: Homoeopathic constitutional remedy based on simile similibus curanter of the individual: Indicated Homoeopathic Medicine will be prescribed for management of nocturnal enuresis bas

Sponsors

DR PRADHNYA SHENDE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Informed consent given by the parents/guardians of children of both sexes in paediatric age group of 5-14 years of diagnosed cases of nocturnal enuresis

Exclusion criteria

Exclusion criteria: 1.Children less than 5 years and more than 14 years of age group. 2. patients on any other medication. 3.patients those are immunocompromised.

Design outcomes

Primary

MeasureTime frame
1)To study the effect of Homoeopathic remedy in improving the quality of life in nocturnal enuresis in paediatric age group 2) To Study the Prevalence of nocturnal enuresis in paediatric age group 5-14 years 3)To study the Gender prevalence of nocturnal enuresis of enrolled sample size. Timepoint: 1) Duration of study is 18 months 2Time points for follow up of 15 days or as when required 3) Duration of each case: case will be managed unto the date of improvement or observed for a period of minimum 6 months

Secondary

MeasureTime frame
1 to study prevalence of nocturnal enuresis in paediatric age group 5-14 years 2.improvement in ORIDL SCALE in case of nocturnal enuresis 3. posology for indicated medicinesTimepoint: follow up of each case will be after 15 days. improvement or observed for a period of six months

Countries

India

Contacts

Public ContactDR PRADHNYA SHENDE

Dr M.L.Dhawale Memorial Homoeopathic Institute,Palghar

sujchan18@gmail.com9323690095

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026